Overview
Cystic fibrosis (CF) is a complex and life-threatening condition that affects approximately 70,000 people worldwide. It is a genetic disorder caused by mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene, which codes for a protein responsible for regulating the movement of salt and water in and out of cells. This abnormal protein leads to the production of thick, sticky mucus that clogs the airways, digestive tract, and other organs, causing a range of symptoms and complications.
CF is a multisystem disorder, affecting the respiratory, digestive, and reproductive systems. The most common symptoms include persistent coughing, wheezing, and shortness of breath, as well as digestive issues such as abdominal pain, bloating, and malnutrition. In severe cases, CF can lead to respiratory failure, liver disease, and other life-threatening complications.
History/Background
Cystic fibrosis was first described in 1938 by Dr. Dorothy Andersen, an American pathologist who identified the condition as a distinct entity. However, the genetic basis of CF was not understood until the 1980s, when the CFTR gene was identified and cloned. Since then, significant advances have been made in the diagnosis, treatment, and management of CF, including the development of gene therapy, lung transplantation, and enzyme replacement therapy.
Key Information
* Prevalence: Cystic fibrosis affects approximately 1 in 2,500 to 1 in 3,500 people worldwide.
* Genetics: CF is inherited in an autosomal recessive pattern, meaning that a person must inherit two defective copies of the CFTR gene (one from each parent) to develop the condition.
* Symptoms: Common symptoms include persistent coughing, wheezing, and shortness of breath, as well as digestive issues such as abdominal pain, bloating, and malnutrition.
* Complications: Severe CF can lead to respiratory failure, liver disease, and other life-threatening complications.
* Treatment: Treatment options include gene therapy, lung transplantation, enzyme replacement therapy, and pulmonary rehabilitation.
Significance
Cystic fibrosis is a significant public health concern, with a high mortality rate and significant economic burden. However, advances in diagnosis, treatment, and management have improved the quality of life and life expectancy for people with CF. Research into CF has also led to a greater understanding of the underlying biology of the condition, which has implications for the development of treatments for other diseases.
